Public Policy Resources

The undersigned public health, medical and professional organizations write in strong support of your recent announcement that FDA will issue a proposed rule to reduce the nicotine level in cigarettes to non-addictive or minimally addictive levels. Such a standard would generate massive public health benefits, preventing millions of young people from smoking and dramatically reducing the number of people who die from tobacco-caused diseases. We urge you to move forward with this proposal as quickly as possible.

The undersigned public health and medical organizations write to express our deep
concern regarding the Food and Drug Administration’s (FDA) failure to take enforcement
actions against new tobacco products, including youth-appealing flavored e-cigarettes, that have
received marketing denial orders (MDOs) yet remain on the market illegally. FDA’s lack of
action against these products, which the agency claims are among its highest enforcement
priorities, imperils the health of our nation’s youth.

The undersigned organizations write to express our concern that FDA has yet to issue any decisions on applications for marketing orders for menthol-flavored e-cigarettes or e-liquid products. We believe granting any such orders would be inconsistent with the agency’s marketing denial orders for other non-tobacco flavored products and would be harmful to public health, particularly to the health of young people.

The undersigned organizations write today to urge you to enforce the Congressionally-mandated deadlines for Premarket Tobacco Product Applications (PMTAs) for synthetic nicotine products and not allow any delays of those deadlines.